Immunomodulatory effects of anti-tumour necrosis factor α: relationships with Behcet disease clinical characteristics

被引：0
|
作者：
Messaoudene, D. [1 ]
机构：
[1] Univ Boumerdes, Boumerdes, Algeria
来源：
IMMUNOLOGY | 2014年 / 143卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
611
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [1] Behcet's disease: a new target for anti-tumour necrosis factor treatment
    Sfikakis, PP
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 : 51 - 53
  • [2] Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behcet's disease
    Triolo, G
    Vadalà, M
    Accardo-Palumbo, A
    Ferrante, A
    Ciccia, F
    Giardina, E
    Citarrella, P
    Lodato, G
    Licata, G
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (06) : 560 - 561
  • [3] Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
    Konstantinos Papamichael
    Severine Vermeire
    World Journal of Gastroenterology, 2015, (16) : 4773 - 4778
  • [4] Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
    Papamichael, Konstantinos
    Vermeire, Severine
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (16) : 4773 - 4778
  • [5] Anti-tumour necrosis factor-α therapies in Crohn's disease
    Sprakes, M. B.
    Hamlin, P. J.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (11) : 644 - 647
  • [6] The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behcet's disease
    Morris, DS
    Gavin, MP
    Sturrock, RD
    ADAMANTIADES-BEHCET'S DISEASE, 2003, 528 : 557 - 559
  • [7] Effects of anti-tumour necrosis factor-α therapy on the quality of life in Crohn's disease
    Van Balkom, BPJ
    Schoon, EJ
    Stockbrügger, RW
    Wolters, FL
    Van Hogezand, RA
    Van Deventer, SJH
    Oldenburg, B
    Van Dullemen, HM
    Russel, MGVM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) : 1101 - 1107
  • [8] Effects of visceral adipose tissue on anti-tumour necrosis factor-α in Crohn's disease
    Li, Kangrong
    Gong, Pan
    Zhang, Yongbin
    Liu, Minji
    Zhang, Zinan
    Yu, Xiaoyu
    Ye, Mingmei
    Tian, Li
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [9] Anti-tumour necrosis factor therapy in clinical practice: what is advance and what is not?
    D'Haens, G
    IMMUNOLOGICAL DISEASES OF LIVER AND GUT, 2004, 135 : 267 - 270
  • [10] BEHCET'S SYNDROME AND ANTI-TUMOUR NECROSIS FACTOR TREATMENT. EFFECTIVITY AND TOLERABILITY IN 6 PATIENTS
    Estrach, C.
    Mpofu, S.
    Moots, R. J.
    RHEUMATOLOGY, 2003, 42 : 92 - 92
12345